TIAA CREF Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-66,533
| Closed | -$9.32M | – | 3039 |
|
|
2018
Q4 | $9.32M | Sell |
66,533
-1,448
| -2% | -$220K | 0.01% | 979 |
|
|
2018
Q3 | $11.6M | Sell |
67,981
-4,367
| -6% | -$734K | 0.01% | 1024 |
|
|
2018
Q2 | $12.6M | Buy |
72,348
+4,416
| +7% | +$664K | 0.01% | 1003 |
|
|
2018
Q1 | $7.84M | Sell |
67,932
-312
| -0.5% | -$33.2K | 0.01% | 1275 |
|
|
2017
Q4 | $5.75M | Sell |
68,244
-3,437
| -5% | -$287K | ﹤0.01% | 1522 |
|
|
2017
Q3 | $6.6M | Buy |
71,681
+16,695
| +30% | +$1.3M | ﹤0.01% | 1447 |
|
|
2017
Q2 | $4.41M | Buy |
54,986
+14,214
| +35% | +$788K | ﹤0.01% | 1674 |
|
|
2017
Q1 | $1.72M | Buy |
40,772
+3,614
| +10% | +$149K | ﹤0.01% | 2225 |
|
|
2016
Q4 | $1.19M | Sell |
37,158
-2,495
| -6% | -$64K | ﹤0.01% | 2440 |
|
|
2016
Q3 | $1.04M | Buy |
39,653
+327
| +0.8% | +$8.56K | ﹤0.01% | 2522 |
|
|
2016
Q2 | $912K | Buy |
39,326
+10,620
| +37% | +$264K | ﹤0.01% | 2560 |
|
|
2016
Q1 | $785K | Buy |
28,706
+2,113
| +8% | +$44.2K | ﹤0.01% | 2606 |
|
|
2015
Q4 | $757K | Buy |
26,593
+805
| +3% | +$21.6K | ﹤0.01% | 2739 |
|
|
2015
Q3 | $451K | Hold |
25,788
| – | – | ﹤0.01% | 2913 |
|
|
2015
Q2 | $465K | Buy |
25,788
+4,757
| +23% | +$65K | ﹤0.01% | 2983 |
|
|
2015
Q1 | $262K | Hold |
21,031
| – | – | ﹤0.01% | 3030 |
|
|
2014
Q4 | $247K | Buy |
21,031
+16,152
| +331% | +$188K | ﹤0.01% | 3077 |
|
|
2014
Q3 | $64K | Buy |
+4,879
| New | +$63.3K | ﹤0.01% | 3115 |
|
Other funds holding LOXO
TIAA CREF Investment Management's LOXO Position: Q1 2019 in Review
TIAA CREF Investment Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 66,533 shares — an estimated $9.32M sold.
TIAA CREF Investment Management first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $12.6M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- TIAA CREF Investment Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- TIAA CREF Investment Management sold 66,533 Loxo Oncology, Inc shares in Q1 2019, an estimated $9.32M.
- TIAA CREF Investment Management first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
- TIAA CREF Investment Management's Loxo Oncology, Inc position peaked at $12.6M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.